Michael Banks, MD, talks about how 2016 Medicaid criteria has allowed for increased access to direct-acting antiviral therapies among patients with hepatitis C virus for whom the costs of the treatments...
Dr James Matera explains the impact of hypertension, chronic kidney disease, and end-stage renal disease on cardiometabolic risk — topics he discussed in his presentation, "Addressing Your Patient's...
Three researchers from the Wolfson Institute for Preventative Medicine, Queen Mary University and The London Hospital offered the argument for just that in the British Journal of Medicine.
